Market Recap: WaMu Surges But Stocks End Flat Minyanville Staff Apr 07, 2008 5:40 pm |
![]() |
![]() |
|
||||||||||||
|
According to Bloomberg, Washington Mutual (WM) surged the most in nearly 25 years after the company said it was expecting $5 billion from private equity firm TPG. This comes after WaMu, the largest savings and loan in the U.S., lost 74% of its market value in the last 12 months. The company was late to the game in the subprime market and posted more than $3 billion in writedowns and loan losses. Further, Standard & Poor’s cut the company’s credit rating last month to BBB from BBB+, two levels above junk status, and added that further reductions were possible. Nonetheless investors were pleased with the company’s move as credit default swaps declined and the stock jumped +29% to $13.15.
Other stocks in the sector got a lift as a result of the news. Notable gainers include UBS (UBS) +3.6% to $34.88. Merrill Lynch (MER) added +2.8% to $47.55. Lehman Brothers (LEH) finished +1.25% to $44.60, and Goldman Sachs (GS) closed +1.9% to $178.73. For more on WaMu, read Minyanville Editor Andrew Jeffery's column, WaMu Shores Up Balance Sheet.
M&A news helped prop up the markets this morning as well. Novartis (NVS), Switzerland’s second-largest drugs company, said it agreed to buy Nestlé’s 77% stake in U.S. company Alcon (ACL). The deal, which could be worth up to $39 billion, would make Novartis the world’s biggest maker of eye-care products. Novartis will first acquire a 25% stake for $11 billion at a 4% discount to ACL’s Friday closing price, but the company will retain the option to acquire the remaining 52% for a fixed price of $28 billion between January 2010 and July 2011, marking a 22% premium. Among the reasons for the acquisition, Novartis CEO Daniel Vasella said “the margins are higher than our pharma business and are obviously very attractive. NVS declined -4% to $50.00, and ACL finished +1.5% to $150.63. Read Toddo’s Monday Morning Point Guard: Bulls Run and Gun.
In tech, Yahoo (YHOO) insisted that Microsoft (MSFT) raise its $31 per share offer, saying the bid undervalued the company. Professor Sean Udall offered his thoughts on the Buzz:
“YHOO's playing a dangerous game. It seems that many pundits don't think MSFT could lower their bid in a hostile situation.
“Why not? MSFT could lower the bid to, say, $28 or so and ask for a vote. Most shareholders know where the stock would go if the merger vote didn't pass. As I said before, the MSFT offer of $31 is solid and frankly came at a time when YHOO really needed a lift.
“After all, where would YHOO have traded (with no bid), before Bear Stearns' (BSC) week after its last quarter and tech analysts downgrading stocks everyday?”
MSFT shares fell -0.17% to $29.16. YHOO lost -2.22% to $27.74. Other notables in the sector include Garmin (GRMN) closing -2.6% to $52.51, Apple (AAPL) added +2.6% to $155.75, and Baidu (BIDU) finished at the $300 mark for a +2.2% gain. Read Toddo’s Random Thoughts.
In commodities, crude oil gained +2.51% to 108.89. Gold gained +14.10 to 923.10. Silver closed +0.3000 to 18.055, and copper rose +0.15 to 398.00.
Check out Professor Ryan Krueger’s Longer-Term Bet on Lower-Cost Oil.
The dollar index gained +024$ to 72.194.
For more Buzz insight, check out Minyanville’s Buzz Bits.
Below is a recap of some of the idea flow on today’s Buzz & Banter. Please note that stocks may appear in both bullish and bearish categories, due to long and short term trades by our many Minyanville professors.
Some bullish trade or investment ideas: MA, SPX, XBD, BKX, AAPL, ASIA, CNTF, DOX, RVBD, NM, MON, SYT, EMC, WBD, DVN, DO, CPKI, KEG, FLS, ISRG, AIG, MER, tran, steel
Some bearish trade or investment ideas: BIDU, JPM, FNM, FRE, FSLR, AEM, VMW, SKX, SCSC, FII, MGM, VMI
The Mondays... the worst is over. Hope you have a great night!
|
|||||||
discuss this article and more on the mv exchange |
|
Get real-time options trading ideas from Steve Smith, veteran options trader and newsletter author, plus let him show you the way to cut risk and boost your returns through the strategic use of options. Click here for a free 14 day trial to OptionSmith by Steve Smith.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2009 Minyanville Media, Inc. All Rights Reserved.
| add rss feed | free article alerts |
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
DC
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennesee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Local Guides


















